111 related articles for article (PubMed ID: 33624755)
1. Antiviral activity and mechanism of ESC-1GN from skin secretion of Hylarana guentheri against influenza A virus.
Yang J; Zhang B; Huang Y; Liu T; Zeng B; Chai J; Wu J; Xu X
J Biochem; 2021 Sep; 169(6):757-765. PubMed ID: 33624755
[TBL] [Abstract][Full Text] [Related]
2. Potent influenza A virus entry inhibitors targeting a conserved region of hemagglutinin.
Lin D; Luo Y; Yang G; Li F; Xie X; Chen D; He L; Wang J; Ye C; Lu S; Lv L; Liu S; He J
Biochem Pharmacol; 2017 Nov; 144():35-51. PubMed ID: 28774731
[TBL] [Abstract][Full Text] [Related]
3. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.
Gerlach T; Hensen L; Matrosovich T; Bergmann J; Winkler M; Peteranderl C; Klenk HD; Weber F; Herold S; Pöhlmann S; Matrosovich M
J Virol; 2017 Jun; 91(11):. PubMed ID: 28356532
[TBL] [Abstract][Full Text] [Related]
4. Esc-1GN shows therapeutic potentials for acne vulgaris and inflammatory pain.
Ye T; Wu J; Xu Z; Chai J; Zeng Q; Zeng B; Gao Y; Guo R; Chen X; Xu X
J Pept Sci; 2020 Aug; 26(8):e3269. PubMed ID: 32558003
[TBL] [Abstract][Full Text] [Related]
5. Temporin G, an amphibian antimicrobial peptide against influenza and parainfluenza respiratory viruses: Insights into biological activity and mechanism of action.
De Angelis M; Casciaro B; Genovese A; Brancaccio D; Marcocci ME; Novellino E; Carotenuto A; Palamara AT; Mangoni ML; Nencioni L
FASEB J; 2021 Feb; 35(2):e21358. PubMed ID: 33538061
[TBL] [Abstract][Full Text] [Related]
6. An Oleanolic Acid Derivative Inhibits Hemagglutinin-Mediated Entry of Influenza A Virus.
Ye M; Liao Y; Wu L; Qi W; Choudhry N; Liu Y; Chen W; Song G; Chen J
Viruses; 2020 Feb; 12(2):. PubMed ID: 32085430
[TBL] [Abstract][Full Text] [Related]
7. Discovery of dihydropyrrolidones as novel inhibitors against influenza A virus.
Liu T; Dai C; Sang H; Chen F; Huang Y; Liao H; Liu S; Zhu Q; Yang J
Eur J Med Chem; 2020 Aug; 199():112334. PubMed ID: 32408213
[TBL] [Abstract][Full Text] [Related]
8. Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin.
Vanderlinden E; Göktas F; Cesur Z; Froeyen M; Reed ML; Russell CJ; Cesur N; Naesens L
J Virol; 2010 May; 84(9):4277-88. PubMed ID: 20181685
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel inhibitor targeting influenza A virus group 2 hemagglutinins.
Du R; Cheng H; Cui Q; Peet NP; Gaisina IN; Rong L
Antiviral Res; 2021 Feb; 186():105013. PubMed ID: 33428962
[TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of formyl peptide receptor 2 antagonists against influenza viruses.
Courtin N; Fotso AF; Fautrad P; Mas F; Alessi MC; Riteau B
Antiviral Res; 2017 Jul; 143():252-261. PubMed ID: 28483551
[TBL] [Abstract][Full Text] [Related]
11. A Novel Mechanism Underlying Antiviral Activity of an Influenza Virus M2-Specific Antibody.
Manzoor R; Eguchi N; Yoshida R; Ozaki H; Kondoh T; Okuya K; Miyamoto H; Takada A
J Virol; 2020 Dec; 95(1):. PubMed ID: 33055251
[TBL] [Abstract][Full Text] [Related]
12. Cell type- and replication stage-specific influenza virus responses in vivo.
Fay EJ; Aron SL; Macchietto MG; Markman MW; Esser-Nobis K; Gale M; Shen S; Langlois RA
PLoS Pathog; 2020 Aug; 16(8):e1008760. PubMed ID: 32790753
[TBL] [Abstract][Full Text] [Related]
13. Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses.
Park JG; Ávila-Pérez G; Nogales A; Blanco-Lobo P; de la Torre JC; Martínez-Sobrido L
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941776
[TBL] [Abstract][Full Text] [Related]
14. Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry.
Wu W; Li R; Li X; He J; Jiang S; Liu S; Yang J
Viruses; 2015 Dec; 8(1):. PubMed ID: 26712783
[TBL] [Abstract][Full Text] [Related]
15. New influenza A Virus Entry Inhibitors Derived from the Viral Fusion Peptides.
Wu W; Lin D; Shen X; Li F; Fang Y; Li K; Xun T; Yang G; Yang J; Liu S; He J
PLoS One; 2015; 10(9):e0138426. PubMed ID: 26382764
[TBL] [Abstract][Full Text] [Related]
16. Novel Anti-Viral Properties of the Herbal Extract of
Chen YL; Chao PY; Hsieh CF; Hsieh PW; Horng JT
Viruses; 2024 Mar; 16(4):. PubMed ID: 38675866
[TBL] [Abstract][Full Text] [Related]
17. Efficient Inhibition of Avian and Seasonal Influenza A Viruses by a Virus-Specific Dicer-Substrate Small Interfering RNA Swarm in Human Monocyte-Derived Macrophages and Dendritic Cells.
Jiang M; Österlund P; Westenius V; Guo D; Poranen MM; Bamford DH; Julkunen I
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463970
[TBL] [Abstract][Full Text] [Related]
18. Probing the effect of quercetin 3-glucoside from Dianthus superbus L against influenza virus infection- In vitro and in silico biochemical and toxicological screening.
Nile SH; Kim DH; Nile A; Park GS; Gansukh E; Kai G
Food Chem Toxicol; 2020 Jan; 135():110985. PubMed ID: 31765700
[TBL] [Abstract][Full Text] [Related]
19. HA-Dependent Tropism of H5N1 and H7N9 Influenza Viruses to Human Endothelial Cells Is Determined by Reduced Stability of the HA, Which Allows the Virus To Cope with Inefficient Endosomal Acidification and Constitutively Expressed IFITM3.
Hensen L; Matrosovich T; Roth K; Klenk HD; Matrosovich M
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597765
[TBL] [Abstract][Full Text] [Related]
20. Antiviral Activity of Chrysin against Influenza Virus Replication via Inhibition of Autophagy.
Kim SR; Jeong MS; Mun SH; Cho J; Seo MD; Kim H; Lee J; Song JH; Ko HJ
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
